LSI is actively seeking partnerships as well as customers for utilizing our sugar-lipid technology/platform on a service-for-fee basis. The company is also exploring in- and out-licensing opportunities.

Benefit of Sugar-Lipid Drug Delivery:

Reformulation of propofol with the sugar-lipid polymer offers benefits to patients that require anesthetics prior to and during medical procedures. Our product benefits over competitors’ products (e.g. Diprivan and 1% Propofol Injectable Emulsion) are:

  • Lower manufacturing costs
  • Improved patient care through reduction of side effects, such as pain on injection
  • Decreases in risks associated with emulsion dosage forms
  • Increase in profitability to hospitals and clinics
  • Sustained competitive advantages through intellectual property protection

Our intellectual properties, technologies and product differentiations will allow LipoSeuticals to capture market share and charge a price commensurate to the brand. These benefits from the sugar-lipid technology can be shared with potential collaborators to match their product development needs